Takeaway
Normobaric hyperoxia in combination with standard endovascular treatment reduces infarction volume in people with acute anterior circulation stroke.
Why this matters?
Neuroprotection is a key component of post-acute ischemic stroke care to slow brain injury processes before treatment occurs; however, there are no neuroprotective drugs with proven clinical efficacy.
This important study supports the use of normobaric hyperoxia with recanalization by endovascular treatment following acute ischemic stroke, with the combined approach providing better long-term outcomes.